Contracts › 36C24226N0216
36C24226N0216: Pluvicto (Lutetium Lu 177 Vipivotide Tetra 27MCI/Ml)
Awarded to Novartis Pharmaceuticals Corporation by Department of Veterans Affairs.
$813Kobligated
$813Kpotential value
31 October 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 36C24226N0216 |
|---|---|
| Vehicle | 36F79720D0180 |
| Awardee | Novartis Pharmaceuticals Corporation |
| Awarding agency | Department of Veterans Affairs |
| Awarding office | 242-NETWORK CONTRACT OFFICE 02 (36C242) |
| NAICS | 325412 Pharmaceutical Preparation Manufacturing |
| PSC | 6505 Drugs and Biologicals |
| Place of performance | NJ |
| Offers received | 1 |
| Period of performance | 01 November 2025 to 31 October 2026 |
| Potential end | 31 October 2026 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 325412 contracts · All expiring contracts · USASpending record